The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The effect of compliance with treatment on survival among patients with hematologic malignancies.
Abstract
Ninety-four newly diagnosed patients with hematologic malignancies were monitored for compliance with oral medication and scheduled clinic appointments over a 6-month treatment period. They were assigned at entry either to a control condition or an intervention condition designed to improve compliance. Compliance with medication was assessed objectively with serial serum drug and metabolite levels, as well as with self-report indices obtained on a monthly basis. Medical records were abstracted to obtain data on the number of appointments kept, treatment given, disease characteristics, and survival. On univariate analyses using the log-rank test, five variables were found to be significantly related to survival. These included compliance with allopurinol (probably acting as a surrogate for self-medication with other chemotherapeutic agents) (P = .007), control versus educational program cohort (P less than .001), disease severity (P = .009), Karnofsky at diagnosis (P = .011), sex (P = .084), and clinic appointments kept (P = .043). In hierarchical proportional hazards models, the following variables were associated with decreased risk of death: disease severity (P less than .025), keeping over 60% of appointments (P less than .05), allopurinol/oxipurinol compliance (P less than .01), and educational program cohort (P less than .05). After controlling for all other variables, three variables were associated with increased survival: high disease severity (relative risk [RR] = 2.48), high compliance with allopurinol (RR = .45), and educational program cohort (RR = .39). We conclude that compliance with oral medication has a significant effect on patient survival. In addition, the use of special educational and supportive programs designed to improve patient compliance are associated with significant prolongation of patient survival due to, as well as independent of their effects on compliance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1979) · Medical Entomology and Zoology · Cited by 11,252
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 2,143
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease
DEVITA, V. T., SERPICK, A. A., & CARBONE, P. P. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-73-6-881 · Cited by 1,436
Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma
McKelvey, E. M., Gottlieb, J. A., Wilson, H. E., Haut, A., Talley, R. W., Stephens, R., Lane, M., Gamble, J. F., Jones, S. E., Grozea, P. N., et al. (1976) · Cancer · doi:10.1002/1097-0142(197610)38:4<1484::aid-cncr2820380407>3.0.co;2-i · Cited by 820
Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
Bonadonna, G., & Valagussa, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040103 · Cited by 774
SCHEIN, P. S., DeVITA, V. T., HUBBARD, S., CHABNER, B. A., CANELLOS, G. P., BERARD, C., & YOUNG, R. C. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-4-417 · Cited by 344
BAGLEY, C. M., DEVITA, V. T., BERARD, C. W., & CANELLOS, G. P. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-2-227 · Cited by 336
Skarin, A. T., Canellos, G. P., Rosenthal, D. S., Case, D. C., MacIntyre, J. M., Pinkus, G. S., Moloney, W. C., & Frei, E. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.2.91 · Cited by 334
A behavioral medicine perspective on adherence to long-term medical regimens.
Epstein, L. H., & Cluss, P. A. (1982) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.50.6.950 · Cited by 279
Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's Disease
SANTORO, A., BONFANTE, V., & BONADONNA, G. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-139 · Cited by 233
Richardson, J. L., Marks, G., & Levine, A. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.11.1746 · Cited by 180
Self-citationCompliance of pediatric and adolescent cancer patients
Tebbi, C. K., Cummings, K. M., Zevon, M. A., Smith, L., Richards, M., & Mallon, J. (1986) · Cancer · doi:10.1002/1097-0142(19860901)58:5<1179::aid-cncr2820580534>3.0.co;2-e · Cited by 178
Pizzo, P. A., Robichaud, K. J., Edwards, B. K., Schumaker, C., Kramer, B. S., & Johnson, A. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80310-2 · Cited by 166
Eney, R. D., & Goldstein, E. O. (1976) · Pediatrics · doi:10.1542/peds.57.4.513 · Cited by 159
Medication Compliance in Patients with Bipolar Disorder
Jamison, K. R., & Akiskal, H. S. (1983) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30847-5 · Cited by 118
Compliance with oral drug therapy in patients with hematologic malignancy.
Levine, A. M., Richardson, J. L., Marks, G. N., Chan, K., Graham, J., Selser, J. N., Kishbaugh, C., Shelton, D. R., & Johnson, C. A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.9.1469 · Cited by 115
Self-citationLiquid-chromatographic measurement of endogenous and exogenous glucocorticoids in plasma.
Frey, F. J., Frey, B. M., & Benet, L. Z. (1979) · Clinical Chemistry · doi:10.1093/clinchem/25.11.1944 · Cited by 102
Path model of multidimensional compliance with cancer therapy.
Richardson, J. L., Marks, G. N., Johnson, C. A., Graham, J. A., Chan, K. K., Selser, J. N., Kishbaugh, C., Barranday, Y., & Levine, A. M. (1987) · Health Psychology · doi:10.1037/0278-6133.6.3.183 · Cited by 80
Self-citationCompliance with disulfiram treatment of alcoholism
Fuller, R. K., Roth, H. P., & Long, S. (1983) · Journal of Chronic Diseases · doi:10.1016/0021-9681(83)90090-5 · Cited by 55
Biology and virology of the human malignant lymphomas.1st Milford D. Schulz lecture
Kaplan, H. S., Goodenow, R. S., Gartner, S., & Bieber, M. M. (1979) · Cancer · doi:10.1002/1097-0142(197901)43:1<169::aid-cncr2820430125>3.0.co;2-f · Cited by 41
Breithaupt, H., & Goebel, G. (1981) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)84228-0 · Cited by 26
Compliance, treatment practices and blood pressure control: Community survey findings
Wagner, E. H., Truesdale, R. A., & Warner, J. T. (1981) · Journal of Chronic Diseases · doi:10.1016/0021-9681(81)90014-x · Cited by 15
Cited by
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Marital Status and Survival in Patients With Cancer
Aizer, A. A., Chen, M.-H., McCarthy, E. P., Mendu, M. L., Koo, S., Wilhite, T. J., Graham, P. L., Choueiri, T. K., Hoffman, K. E., Martin, N. E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6489 · Cited by 1,031
Fawzy, F. I. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210015002 · Cited by 1,028
Metadata
- Authors
- Richardson, J. L., Shelton, D. R., Krailo, M., & Levine, A. M.
- Venue
- Journal of Clinical Oncology
- Published
- 1990-02
- Volume
- 8
- Issue
- 2
- Pages
- 356-364
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2178871496
- Cited by
- 305
- References
- 24
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.